Search research articles
Contact Us
Filters
Showing results (1-10 of 184) with videos related to
Page
of 19
Sort By:
Journal of Gastroenterology and Hepatology
|
December 23, 2011
How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
Grace L-H Wong
Genome Research
|
April 3, 2001
Centromere on the move
L H Wong, K H Choo
Alimentary Pharmacology & Therapeutics
|
December 28, 2019
Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply
Terry C-F Yip, Grace L-H Wong
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2019
Reply to Boglione et al
Grace C Y Lui, Grace L H Wong
Drugs
|
October 27, 2009
Predictors of treatment response in chronic hepatitis B
Grace L-H Wong, Henry L-Y Chan
Journal of Hypertension : Open Access
|
March 19, 2016
Racial Differences Affecting Night Time Blood Pressure Dipping Groups in Hypertensive Patients
L H Wong, Huang Elaine, R T Kong
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
March 9, 2022
Dynamic change of LSM-HCC score and enhanced liver fibrosis score to predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment: abridged secondary publication
G L H Wong, V W S Wong
Alimentary Pharmacology & Therapeutics
|
September 17, 2016
Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' reply
G L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics
|
October 11, 2011
Medical therapy for primary sclerosing cholangitis
G L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics
|
April 17, 2014
Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - authors' reply
G L-H Wong, V W-S Wong
Page
of 19
Search research articles
Search
Showing results (1-10 of 184) with videos related to
Sort By:
Page
of 19
Journal of Gastroenterology and Hepatology
|
December 23, 2011
How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
Grace L-H Wong
Genome Research
|
April 3, 2001
Centromere on the move
L H Wong, K H Choo
Alimentary Pharmacology & Therapeutics
|
December 28, 2019
Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply
Terry C-F Yip, Grace L-H Wong
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2019
Reply to Boglione et al
Grace C Y Lui, Grace L H Wong
Drugs
|
October 27, 2009
Predictors of treatment response in chronic hepatitis B
Grace L-H Wong, Henry L-Y Chan
Journal of Hypertension : Open Access
|
March 19, 2016
Racial Differences Affecting Night Time Blood Pressure Dipping Groups in Hypertensive Patients
L H Wong, Huang Elaine, R T Kong
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
March 9, 2022
Dynamic change of LSM-HCC score and enhanced liver fibrosis score to predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment: abridged secondary publication
G L H Wong, V W S Wong
Alimentary Pharmacology & Therapeutics
|
September 17, 2016
Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' reply
G L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics
|
October 11, 2011
Medical therapy for primary sclerosing cholangitis
G L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics
|
April 17, 2014
Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - authors' reply
G L-H Wong, V W-S Wong
Page
of 19